With the rapid development of precision medicine, targeted drugs have become a key approach in cancer treatment. Unlike traditional chemotherapy, targeted therapy “hits” specific...
The U.S. Food and Drug Administration has granted approval to Otsuka’s newly developed injectable therapy for patients diagnosed with primary immunoglobulin A nephropathy (IgAN), ...